Azelastine/Budesonide

氮卓斯汀/布地奈德

Report date: 2025/11/27 15:17:36

Base Information

Drug NameAzelastine/Budesonide
Drug Alias Name布地奈德/盐酸氮卓斯汀Azelastine/budesonide布地奈德+盐酸氮卓斯汀Budesonide/Azelastine HydrochlorideAzelastine Hydrochloride/Budesonide +[12] 
ClassificationSmall molecules > Steroids
Mechanisms of ActionGlucocorticoid receptor agonistsHistamine H1 receptor antagonists
TargetsHistamine H1 receptorGlucocorticoid receptor
Therapy Area/IndicationsRhinitis, Allergic, Seasonal
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsYes BudesonideAzelastine Hydrochloride
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesLigand Pharmaceuticals Inc
China Registration ClassN/A

Develop Information

Active CompaniesSedor PharmaceuticalsLigand Pharmaceuticals Inc
Inactive CompaniesN/A
Active IndicationsRhinitis, Allergic, Seasonal
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A